课题基金 / 基金详情

项目摘要

项目成果

PENG JIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epigenetics is broadly defined as the heritable changes in gene expression and function that do not alter DNA sequence. As an intermediate regulatory paradigm between DNA sequences and gene expression, epigenetic mechanisms can exert substantial influence on brain development on a scale that we are only beginning to appreciate. Furthermore increasing evidence indicates that multiple neurodevelopmental, neurodegenerative, and psychiatric disorders are caused, at least in part, by aberrant epigenetic modifications. Cytosine methylation serves as a critical epigenetic mark by modifying DNA-protein interactions that influence transcriptional states and cellular identity. 5-methylcytosine (5mC) has generally been viewed as a stable covalent modification to DNA; however, the fact that 5-mC can be enzymatically modified to 5- hydroxymethylcytosine (5hmC) by Tet family proteins through Fe(II) α-KG-dependent hydroxylation gives a new perspective on the previously observed plasticity in 5mC-dependent regulatory processes. Epigenetic plasticity in DNA methylation-related regulatory processes influences activity-dependent gene regulation and learning and memory in the central nervous system (CNS). Hydroxylation of 5mC to 5hmC presents a particularly intriguing epigenetic regulatory paradigm in the mammalian brain, where its dynamic regulation is critical. Emerging evidence also suggests potential epigenetic roles for a novel DNA adenosine modification, N6- methyladenine (N6mA). Thus the discovery of both 5hmC/5fC/5caC and N6mA in mammalian genome significantly increases the DNA epigenetic complexity and intriguingly all these modifications are enriched in brain. The proposed works here will integrate various disciplines (genetics/genomics, bioinformatics, biochemistry, and cell biology) to understand the crosstalk among the dynamic DNA modifications during neurodevelopment and aging, and their roles in the pathogenesis of neurological disorders.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1126/sciadv.add6391
发表时间: 2022-11-25
期刊: Science advances
影响因子: 13.6
作者: []
通讯作者:
Dysregulated mitochondrial and cytosolic tRNA m1A methylation in Alzheimer's disease.
阿尔茨海默病中线粒体和胞质 tRNA m1A 甲基化失调。
DOI: 10.1093/hmg/ddab357
发表时间: 2022
期刊: Human molecular genetics
影响因子: 3.5
作者: [Shafik,AndrewM, Zhou,Huiqing, Lim,Junghwa, Dickinson,Bryan, Jin,Peng]
通讯作者: Jin,Peng
Cell-free DNA methylation as a potential biomarker in brain disorders.
游离 DNA 甲基化作为脑部疾病的潜在生物标志物。
DOI: 10.2217/epi-2021-0416
发表时间: 2022
期刊: Epigenomics
影响因子: 3.8
作者: [Jin,Yulin, Allen,EmilyG, Jin,Peng]
通讯作者: Jin,Peng
DOI: 10.1093/hmg/ddab167
发表时间: 2021-06
期刊: Human molecular genetics
影响因子: 3.5
作者: [C. Meng;Lei Gu;Yujing Li;Ronghua Li;Yiqu Cao;Ziyi Li;E. Allen;Dongdong Zhu;P. Jin]
通讯作者: C. Meng;Lei Gu;Yujing Li;Ronghua Li;Yiqu Cao;Ziyi Li;E. Allen;Dongdong Zhu;P. Jin
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
  • 批准号:
    10682494
  • 项目类别:
  • 资助金额:
    $76.32万
  • 财政年份:
    2022
  • 负责人:
    PENG JIN
  • 依托单位:
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
  • 批准号:
    10518654
  • 项目类别:
  • 资助金额:
    $77.75万
  • 财政年份:
    2022
  • 负责人:
    PENG JIN
  • 依托单位:
FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement
  • 批准号:
    10443845
  • 项目类别:
  • 资助金额:
    $160.0万
  • 财政年份:
    2020
  • 负责人:
    PENG JIN
  • 依托单位:
Administrative Core
  • 批准号:
    10443846
  • 项目类别:
  • 资助金额:
    $18.3万
  • 财政年份:
    2020
  • 负责人:
    PENG JIN
  • 依托单位:
海外基金